Evidence map›Paper›PMID 26622897›Full record

ArticleOncology letters2015

MicroRNA-650 in a copy number-variable region regulates the production of interleukin 6 in human osteosarcoma cells.

Jun Ho Yun, Sanghoon Moon, Heun-Sik Lee, Mi Yeong Hwang, Yeon-Jung Kim, Ho-Yeong Yu, Youngsoo Kim, Bok-Ghee Han, Bong-Jo Kim, Jeong-Min Kim

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Functions and mechanisms of miR-650 in human diseases.Frontiers in molecular biosciences · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. MicroRNAs in Genetic Etiology of Human Diseases.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jun Ho YunCenter for Genome Science, Korea National Institute of Health, Cheongju, Chungcheongbuk-do 361-951, Republic of Korea ; College of Pharmacy, Chungbuk National University, Cheongju, Chungcheongbuk-do 361-763, Republic of Korea.
Sanghoon MoonCenter for Genome Science, Korea National Institute of Health, Cheongju, Chungcheongbuk-do 361-951, Republic of Korea.
Heun-Sik LeeCenter for Genome Science, Korea National Institute of Health, Cheongju, Chungcheongbuk-do 361-951, Republic of Korea.
Mi Yeong HwangCenter for Genome Science, Korea National Institute of Health, Cheongju, Chungcheongbuk-do 361-951, Republic of Korea.
Yeon-Jung KimCenter for Genome Science, Korea National Institute of Health, Cheongju, Chungcheongbuk-do 361-951, Republic of Korea.
Ho-Yeong YuCenter for Genome Science, Korea National Institute of Health, Cheongju, Chungcheongbuk-do 361-951, Republic of Korea.
Youngsoo KimCollege of Pharmacy, Chungbuk National University, Cheongju, Chungcheongbuk-do 361-763, Republic of Korea.
Bok-Ghee HanCenter for Genome Science, Korea National Institute of Health, Cheongju, Chungcheongbuk-do 361-951, Republic of Korea.
Bong-Jo KimCenter for Genome Science, Korea National Institute of Health, Cheongju, Chungcheongbuk-do 361-951, Republic of Korea.
Jeong-Min KimCenter for Genome Science, Korea National Institute of Health, Cheongju, Chungcheongbuk-do 361-951, Republic of Korea.
Korea National Institute of Health · KRChungbuk National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Copy number variation is a well-known genetic variation. microRNAs (miRNAs/miRs) are non-coding RNAs that mediate gene expression by regulating target mRNAs. In the present study, copy number deletions encompassing miRNA coding regions were investigated to determine the association between the deletion of miRNA and its phenotypic effects. A total of 38 human miRNAs in copy number variants were identified and miR-650, which is functional in the human osteosarcoma MG-63 cell line, was selected. Overexpression of miR-650 decreased the expression of inhibitor of growth family member 4 (ING4) in the MG-63 cells and increased interleukin (IL)6 transcription, as well as IL6 secretion in IL1B-stimulated cells. Furthermore, miR-650 downregulated the amount of nuclear factor of κ light polypeptide gene enhancer in B cells inhibitor α and increased the transcriptional activity of nuclear factor (NF)κB. Downregulation of ING4 also increased the production of IL6, similar to miR-650 overexpression. Taken together, these data indicate that miR-650 plays a significant role in the production of IL6 by regulating ING4 expression and NFκB signaling in IL1B-stimulated MG-63 osteosarcoma cells.

Indexed as

copy number variationING4interleukin 6microRNA-650

Identifiers

PMID26622897
PMCPMC4580027
OpenAlexW2123337916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.